Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
about
Concomitant use of contraceptives and potentially teratogenic medicinal products--results from a study using pharmacy dispensing data in the Netherlands.Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands: a retrospective cohort studyA comparison of pregnancy prevention programmes in Europe.Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Assessment of medication adherence and responsible use of isotretinoin and contraception through Belgian community pharmacies by using pharmacy refill data.Ethical and Psychosocial Considerations in Informing HIV-Exposed Uninfected Children That They Were Exposed to HIV and Antiretroviral Medications In Utero.Contraindicated use of 5-alpha-reductase inhibitors in women.Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016.Isotretinoin; A review on the Utilization Pattern in Pregnancy
P2860
Q34243094-9990AA15-603C-4D9A-BAAC-19AFBE5419F9Q34573521-FC3953BE-16E1-44CE-9087-AB89326100CCQ34692840-42A819B3-6600-493A-84C3-640D63EED350Q35216460-9F38C2F5-8C38-4A54-90E6-56D087D0CD0DQ43503716-19AAB38D-C53E-459F-A5F0-D2B8418F53EBQ46143031-D790CBB5-46D5-4070-AF5B-87E61BB0A3ACQ46199009-060C51BA-25C9-4618-9A10-A9A94867E695Q46869716-0A833AE2-2815-449F-9C00-0C1C8E1329BDQ47326209-028AFBF5-C0FD-46E0-81BB-23FCE7BC13CEQ47653552-EB15C4F3-165C-488D-9C36-694ADD96021EQ49515110-27754673-3070-45B0-91BD-408BCFFE433DQ54574017-DB3BA9E9-080C-4FF7-829F-B9DEAEA38EB9Q54848156-9D7320E8-479E-40C1-A4B3-796DAA925914Q55240820-8BA0A5B8-D2B0-42A8-825E-06AC7C929095Q57136258-3DC58864-D718-4BF2-8211-D72C82292B25
P2860
Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@ast
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@en
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@nl
type
label
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@ast
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@en
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@nl
prefLabel
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@ast
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@en
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@nl
P2093
P1433
P1476
Isotretinoin use and complianc ...... sing pharmacy dispensing data.
@en
P2093
Bruno H Ch Stricker
Eline Rodenburg
Loes E Visser
Mark Dufour
Martina Teichert
Peter A G M De Smet
Sabine M J M Straus
P304
P356
10.2165/11319190-000000000-00000
P577
2010-04-01T00:00:00Z
P6179
1024806559